It is commonly assumed high cholesterol contributes to atherosclerosis which initiates with foamy macrophages. Here it is suggested the induction of foam in human macrophages relates instead to the induction of a newly described foamy virus, human endogenous retrovirus K102 (HERV-K102) in response to high cortisol and/or viruses, other intracellular pathogens, or tumors. HERV-K102 is a newly described human host protection mechanism and the particles are replication competent in vitro and in vivo. In healthy or younger adults, the foamy macrophages lyse on day 7 and release the protective HERV-K102 particles. When immunosenescence is evident (associated with low DHEA and high cortisol) the lysis and release of the HERV-K102 particles is blocked by alpha-fetoprotein (AFP). The dysfunctional and partly activated macrophages promote immunosenescence including atherosclerosis. See Laderoute MP, Discovery Medicine article published December 2015 for more details.
Dr. Laura Miller - Comparative analysis of signature genes in PRRSV-infected ...John Blue
Comparative analysis of signature genes in PRRSV-infected porcine monocyte-derived dendritic cells at differential activation statuses - Dr. Laura Miller, Virus and Prion Diseases of Livestock Research Unit, National Animal Disease Center, USDA-ARS, from the 2015 North American PRRS Symposium, December 4 - 5, 2015, Chicago, IL, USA.
More presentations at http://www.swinecast.com/2015-north-american-prrs-symposium
Dr. Laura Miller - Comparative analysis of signature genes in PRRSV-infected ...John Blue
Comparative analysis of signature genes in PRRSV-infected porcine monocyte-derived dendritic cells at differential activation statuses - Dr. Laura Miller, Virus and Prion Diseases of Livestock Research Unit, National Animal Disease Center, USDA-ARS, from the 2015 North American PRRS Symposium, December 4 - 5, 2015, Chicago, IL, USA.
More presentations at http://www.swinecast.com/2015-north-american-prrs-symposium
Sanja Selak of Intercell AG, Vienna, Austria, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Intercell develops vaccines for the prevention and treatment of infectious diseases
NAD-Glycohydrolase Depletes Intracellular NAD+ and Inhibits Acidification of Autophagosomes to Enhance Multiplication of Group A Streptococcus in Endothelial Cells
HIV-1 Control: Exploiting the HERV-K102 - AFP Immunosenescence ParadigmDr. Marian Laderoute
This slide deck reviews evidence supporting a role of the HERV-K102-AFP immunosenescence paradigm in HIV-1 pathogenesis. It also discusses how this paradigm could be exploited for HIV-1 cure and therapeutic vaccines. Moreover, that human endogenous retrovirus K102 (HERV-K102), which is a foamy retrovirus unique to humans, could be used for gene therapy against HIV-1 as a replication competent (possibly transmissible) protector virus for a sterilizing cure/vaccine. A must read for anyone working on the HIV cure or vaccine.
Sanja Selak of Intercell AG, Vienna, Austria, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Intercell develops vaccines for the prevention and treatment of infectious diseases
NAD-Glycohydrolase Depletes Intracellular NAD+ and Inhibits Acidification of Autophagosomes to Enhance Multiplication of Group A Streptococcus in Endothelial Cells
HIV-1 Control: Exploiting the HERV-K102 - AFP Immunosenescence ParadigmDr. Marian Laderoute
This slide deck reviews evidence supporting a role of the HERV-K102-AFP immunosenescence paradigm in HIV-1 pathogenesis. It also discusses how this paradigm could be exploited for HIV-1 cure and therapeutic vaccines. Moreover, that human endogenous retrovirus K102 (HERV-K102), which is a foamy retrovirus unique to humans, could be used for gene therapy against HIV-1 as a replication competent (possibly transmissible) protector virus for a sterilizing cure/vaccine. A must read for anyone working on the HIV cure or vaccine.
dkNET Webinar: Leveraging Computational Strategies to Identify Type 1 Diabete...dkNET
dkNET New Investigator Pilot Program in Bioinformatics Awardee Webinar Series
Presenter: Wenting Wu, PhD. Research Assistant Professor, Center for Diabetes and Metabolic Diseases, Department of Medical and Molecular Genetics, Associate Director of Data and Analytics Core for Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine
Abstract
Type 1 diabetes (T1D) is an immune-mediated disease that results in insulin insufficiency and affects 0.3% of the population, including both children and adults. To support clinical trial efforts, there is an urgent need to develop reliable biomarkers capable of predicting T1D risk and guiding therapeutic interventions. Recently, whole blood bulk RNA sequencing has been used to guide T1D clinical trial design and assess response to disease modifying interventions. While the use of bulk RNA sequencing is cost-effective, these datasets provide limited information about cell specific gene expression changes. Here, we aimed to apply computational strategies to deconvolute cell type composition using cell specific gene expression references. Single-cell RNA sequencing (scRNA-seq) was conducted to profile peripheral blood mononuclear cells obtained from youth within recent T1D onset and age- and sex-matched controls and identified 31 distinct cell clusters. Using this pre-defined reference dataset, we ran computational algorithms CIBERSORTx and other deconvolution methods simultaneously to deconvolute cell proportions using public clinical trial data. We focused our initial analysis on data from the TN-20 Rituximab trial, which tested the anti-CD20 monoclonal antibody rituximab vs placebo in recent onset T1D. This talk will introduce recent advances of scRNA-seq techniques and computational deconvolution methods and demonstrate that how we apply different deconvolution approaches for secondary analysis of existing clinical trial data, in the purpose of linking cell specific immune signatures associated with drug responder status.
Upcoming webinars schedule: https://dknet.org/about/webinar
Gene Olinger, USAMRIID, Fort Detrick USA, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Protective Immune Reponses to Ebola Virus
By identifying key cells and cytokines that play roles in the development of diseases like psoriasis and atopic dermatitis, we have been able to target very specific parts of the immune system and thereby treat these diseases more effectively and more safely. Following the same methodology, we hope to identify key targets that allow us to do the same for alopecia areata.
This presentation covers a brief introduction to Diagnostic kit with its different types and examples. Also, this presentation covers examples of some common diseases with their diagnostic test.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Atherosclerosis: New Insights on Foamy Macrophage Induction and Persistence
1. New Insights on
Mechanisms of
Foamy
Macrophage
(FM)
Induction and
Persistence
Canadian Hypertension Congress
October 17, 2014
Gatineau, Quebec
2. Marian Laderoute,
Ph.D. Medical Sciences -Immunology
Lab Director (2011-2015)
Immune System Management
Clinic & Lab
80 Aberdeen Street, Ottawa, On
Tel: (613) 656-0983
Email: mladeroute@ismclinic.com
Website: www.aminomics.com
3. Atherosclerosis (hardening of arteries) initiates with foamy
macrophages
From: Lo J & Plutzky J. J Inf Diseases 2012; 205:S368-74.
Foamy
Macrophage
(FM)
4. Human Macrophages Undergo Spontaneous Foam Cell
Formation Without the Need for Lipid or TLR Signalling
M1 human monocyte-derived macrophages
(GM-CSF) undergo spontaneous foam cell
formation (when cells cultured in DMEM).
Spontaneous foam cell formation is not found in
murine systems nor in human monocytic
leukemic cell lines, which instead requires
oxLDL and/or Toll Like Receptor (TLR) signaling.
Keyel PA et al, Coordinate stimulation of macrophages by microparticles and TLR
ligands induces foam cell formation. J. Immunol, 2012 189:4621.
5. Foamy Macrophages are Also Associated with Tumors
and Viral Infections
(where a role of elevated cholesterol is less obvious).
Foamy Macrophages in Lymph Nodes
Adjacent to Tumor
Foamy Macrophages in Brain with Re-
activated John Cunningham Virus (JCV)
From: Vaklavas C et al, Virol J 2010, 7:256.
6. So what causes foamy macrophages in humans?
Electron Microscopy of Cord Blood mononuclear cells (CB)
One cause of a certain type of foamy macrophage appears to be
the induction of endogenous (foamy) retrovirus particles.
Culture of
CB in IMDM
Media
instead of
RPMI
No viral budding from cell surface, therefore
RELEASE of Particles is ONLY through cell lysis.
7. Human Endogenous Retroviruses
(HERVs)
▪8% of human genome involves HERVs
▪named according to the amino acid transfer RNA used
for reverse priming for integration into host genome
▪HERV-K HML-2 proviruses are the most recent and
biologically active
▪Antibodies to HERV-K antigens found in many diseases
▪The foamy retrovirus of humans has not been
discovered, but most mammals have their own foamy
retroviruses.
8. An Inducible Endogenous Human Foamy Virus from
Normal Cord Blood (CB) Identified as HERV-K102
A B C
E
HERV-K102polRNAbyqPCRddCt
D
Sequencing of
excised pol
bands revealed
only HERV-
K102 pol (6/6
CB samples)
HERV-K102 pol RNA expression
confirmed by qPCR ddCtHML-2 pol expression
Laderoute MP et al.,
Open AIDS Journal,
2015
9. HERV-K102 Env Expression and Env Processing were Detected
(key for particle production and infectivity, respectively, of foamy viruses)
A
Day
0
Day
7
C ML4 Antibody ML5 Antibody ALG
B
IgG
90 kDa
55 kDa
Day 7
Immunoprecipitates
Day 0
Immunoprecipitates
ML4 ML5 C ML4 ML5 C
Laderoute MP et al, Open AIDS Journal,
2015
Altogether these in vitro results suggested HERV-K102
might form particles in vivo and be replication competent.
10. • HERV-K102 particles can be isolated from plasma during acute disease which
disappear upon remission: not isolated from 30 normal adult plasma samples.
Spiked Control* CFS Acute EBV MS initial MS prog CB#1 CB#2
* Normal plasma spiked with 500,000 PBMCs (uninduced) then processed with the
plasma virus isolation kit.
• The genomes are predominately DNA (cDNA) confirming they are foamy retroviruses
(FV) with a reversed life cycle to most other retroviruses.
NB: 2 of 4 normal CB had
HERV-K102 particles
consistent with known
non-pathogenicity of FV
Laderoute MP et al., AIDS, 2007.
11. HERV-K102 particles are also produced
in response to viral infections
(HERV-K102 pol ddCt ratios on plasma DNA ).
Cohort % Positive Ratios
(positive/total cutoff 1.60)
HERV-K102 pol
ddCt ratio - RANGE -
Normal 3.3% (1/30) 0.41 to 1.74 a
Hepatitis B and C 78.6% (22/28) * 0.81 to 4.32 x 109
Herpes 61.9% (13/21) * 0.24 to 2.02 x 109
HIV-1 75.7 % (28/37)* 0.49 to 1.22 x 102
a) Mean ddCt ratio was 0.88 +/- 0.37 in 30 serologically negative normals, and no particles could be isolated
p<0.0001 Fisher exact test when compared to normal by nonparametric proportions.
Antagonism
Laderoute MP et al., AIDS, 2007.
12. Evidence of HERV-K102 Particle Production in the
Antagonism of HIV-1 Replication In Vivo
Study of HERV-K102 pol gene copy numbers in HESN commercial sex trade workers (CSW)
versus HIV-1 infected individuals by real time PCR on plasma DNA
P =0.0005 (Normal control ddCt ratios =0.88 +/- 0.37)
1. Confirms HERV-K102
likely replication
competent and/or
infectious in vivo
2. HERV-K102 particle
production/activity
might antagonize HIV-1
replication/transmission
From: Laderoute
MP et al., Open
AIDS Journal,
2015
13. Summary of Current Status on Human
Endogenous Retrovirus K102 (HERV-K102)
▪ HERV-K102 has hallmark features and genetic motifs of non-
pathogenic foamy retroviruses (FV)
▪ is replication competent reaching 1011 particles per ml of plasma
in just a few days (dns)
▪ HERV-K102 is unique to humans, not found in other species
▪ Accumulating evidence suggests HERV-K102 is protective and
may be an inflammatory (innate immunity) response to viruses,
tumors, toxins and/or stress and may also induce autoimmune
reactivity (T and B cell responses) against abnormal cells (tumor
transformed or infected) expressing HERV-K antigens (Wang-
Johanning, Nixon, Markovitz, Laderoute)
▪ HERV-K102 has a glucocorticoid response element (Ono M, 1986) and
thus, likely is directly induced by cortisol
14. Working Model for
Foamy Macrophage (FM) Persistence in Atherosclerosis
Cortisol, viruses,
tumors,
toxins,
stress, etc Lysis
HERV-
K102
particle
release
Pathogen/
tumor
Clearance/
control
BLOCKED LYSIS
ATHEROSCLEROSIS
Immunosuppressed
Host Flavonoids
HERV-K102
Particle
Production
WellnessModified from:
Laderoute MP, Discovery
Medicine, 2015
15. Flavonoids Are Known to
Reduce Cardiovascular Deaths,
Yochum L et al, Am J Epi 1999, 149:943-949.
may protect against cardiovascular disease as has
been shown for the following: (see review by Bhardwaj P et al, 2013),
Atherosclerosis, Hypertension, Endothelial dysfunction, Ischemic heart disease, Cardiomyopathy, Congestive heart
failure, Inflammatory responses, Oxidative Stress, Platelet aggregation, Proliferation of vascular smooth muscle
cells
And, may lead to normalization of the DHEA:cortisol ratio as well as rebalance
immunoreactivity favoring Th1 over Th2 associated with a decline in IL-6.
Bouic P & Lamprecht J, Alternative Medicine Review 1999, 4: 170-177.
16. Induction of foamy macrophages can be a normal host
inflammatory response involving particle production of an
endogenous FOAMY virus, identified as HERV-K102 in
response to intracellular pathogens and/or tumors.
However, foamy macrophage persistence and resulting
atherosclerosis might signify active immunosuppression,
stress, and/or persistent pathogens which should be
eliminated or treated, and not necessarily high cholesterol per se.
FOAMY MACROPHAGE
INDUCTION & PERSISTENCE
Summary
17. Dr. Marian
Laderoute
https://www.linkedin.com/in/hervk102
REFERENCES:
Laderoute MP, Giulivi A, Larocque L, Bellfoy D, Hou Y, Wu HX,
Fowke K, Wu J, Diaz-Mitoma F. The replicative activity of
human endogenous retrovirus K102 (HERV-K102) with HIV
viremia. AIDS 21:2417-2424, 2007.
Laderoute MP. Why is February Heart Month? 2014. Article
available online at
http://www.aminomics.com/professionals/research_pdf/Why-
isFebHeart-month.pdf. Accessed October 29, 2015.
Laderoute MP, Larocque LJ, Giulivi A, Diaz-Mitoma F. Further
evidence that human endogenous retrovirus K102 is a
replication competent foamy virus that may antagonize HIV-1
replication. Open AIDS Journal 9:79-89, 2015.
Laderoute MP. A new paradigm about HERV-K102 particle
production and blocked release to explain cortisol mediated
immunosenescence and age-associated risk of chronic
disease. Discovery Medicine 20 (112): 379-391, 2015.